Cognitive & Mood Dietary supplement

Lithium Orotate

Low-Dose Lithium · Lithium Orotate Salt

Evidence: Studied in humans. Example dose: finalize with a provider. Not a fact-check stamp.

5mg elemental lithium – 5-10 mg elemental Oral Daily

Lithium Orotate is a low-dose lithium salt formed by combining lithium with orotic acid - a precursor in pyrimidine biosynthesis. Unlike pharmaceutical lithium carbonate (used for bipolar disorder at 600-1800mg/day delivering 100-300mg elemental lithium), Lithium Orotate is sold as a dietary supplement at low doses delivering only 1-20mg elemental lithium per capsule. The low-dose lithium concept is based on the hypothesis that humans are widely deficient in trace lithium (which occurs naturally in drinking water at varying concentrations) and that supplementation at sub-pharmaceutical doses provides neuroprotective and mood-stabilizing benefits without the toxicity concerns of full-dose lithium therapy.

Quick Start

Route

Oral

Start low

5mg Oral

Frequency

Daily

Timing

Anytime

Take with food. Standard dose 5-10mg elemental lithium daily (often Lithium Orotate 120mg = 5mg elemental). Higher doses (15-20mg elemental) for more pronounced mood/cognitive effects. Pairs naturally with B-complex (especially B12 + folate) and omega-3.

❋

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first

Conservative start

5mg elemental lithium · Oral · Daily

conservative starter

5mg elemental lithium

Daily

Standard

Neuroprotective Microdose

5-10 mg elemental · Oral · Daily

human study · Schrauzer 2002 (J Am Coll Nutr)

NO MODERN CONTROLLED TRIAL OF LITHIUM OROTATE EXISTS - zero registered studies, and all controlled human lithium data uses the carbonate or citrate salt. The 150 mg/day figure that circulates traces to an uncontrolled, unblinded 1986 case series in 42 alcohol-rehabilitation patients with no serum lithium levels reported and several other compounds co-administered. Our dose is deliberately conservative. Prescription lithium requires renal and thyroid monitoring, and that caution reasonably carries over.

5-10 mg elemental

Daily

◆

How it works

Lithium's primary mechanisms include inhibition of glycogen synthase kinase-3 (GSK-3 alpha and beta), modulation of inositol monophosphatase (lithium inhibits IMPase, reducing inositol/PIP2 second messenger signaling), and promotion of brain-derived neurotrophic factor (BDNF) expression. GSK-3 inhibition is particularly relevant for neuroprotection: GSK-3 phosphorylates tau protein in pathological hyperphosphorylation patterns; lithium inhibition reduces tau pathology and is implicated in Alzheimer's prevention research.

BDNF upregulation by lithium supports synaptic plasticity, neurogenesis (especially in hippocampus), and dendritic branching. This is mechanistically relevant for both mood stabilization (BDNF deficits associated with depression) and cognitive enhancement. Lithium also supports glutamate-GABA balance, modulates serotonergic signaling, and has direct anti-apoptotic effects on neurons exposed to oxidative stress or excitotoxicity.

At low doses (5-20mg elemental), the cellular effects are weaker than pharmaceutical lithium (100-300mg), but emerging evidence suggests significant biological effects can occur at trace doses. The orotate component supplies pyrimidine precursors for nucleotide synthesis and may have independent metabolic effects, though lithium is the primary active. Compared to lithium carbonate (the pharmaceutical form), lithium orotate is sometimes claimed to penetrate cells more effectively (the 'orotate carrier' hypothesis), though this is debated and not well-established.

What to expect

Early

Days 1–7

Days 1-14: Subtle mood/calm effects.

Evidence

HumanPresent

AnimalPresent

In-vitroPresent

Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.

Evidence boundary from the checked abstract: Lithium orotate proved useful as the main pharmacologic agent for the treatment of alcoholism.

Lithium orotate proved useful as the main pharmacologic agent for the treatment of alcoholism.

Lithium orotate in the treatment of alcoholism and related conditions. Alcohol (Fayetteville, N.Y.) · 1986 · PMID 3718672

Evidence scope. This entry supports only the exact statement quoted from the live abstract; it does not independently verify OnePin's displayed dose, route, frequency, formulation, population, or broader mechanism.

Claims we could not support

No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.

Dose/route: 5mg elemental lithium; Oral; Daily. No checked live PubMed abstract verified this exact displayed dose, route, and frequency for the same molecule/formulation and relevant population.

Primary safety claim: Mild GI effects (nausea, diarrhea) - take with food. No checked live PubMed abstract directly verified this source-JSON safety claim at the displayed formulation, route, and regimen.

Interactions & stacking

Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.

Documented together

L-TheanineBoth support calm focus through different mechanisms.

Most adaptogens (Ashwagandha, Rhodiola)Compatible mood/stress support.

Omega-3 (DHA/EPA)Both support neuronal membrane function and BDNF expression. Common mood/cognitive stack.

B12 + MethylfolateBoth support methylation and neurotransmitter synthesis. Foundational mood support.

Keep separate

Pharmaceutical Lithium (Lithium Carbonate)Combining supplemental lithium with prescription lithium can elevate blood levels into toxic range. NEVER combine without explicit physician supervision.

NSAIDs (Ibuprofen, Naproxen)NSAIDs reduce renal clearance of lithium, potentially increasing blood levels. Significant for pharmaceutical lithium; relevance at supplement doses lower but worth noting.

Diuretics (especially Thiazides)Thiazide diuretics reduce lithium clearance; loop diuretics may also affect lithium levels.

ACE Inhibitors / ARBsCan reduce lithium clearance and increase blood levels.

Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.

Pharmacokinetics

Illustrative plasma concentration · 4 d

Half-life

~24 hours

Lithium ion

Peak · Tmax

~1-2 hours

Oral

Elimination

~3-5 days

Bioavailability

~95%

Oral - lithium is essentially fully absorbed regardless of salt form.

Duration of action

Cellular effects sustained with daily dosing. Levels reach steady state after 5-7 days.

Clearance

Renal excretion (minimal metabolism). Sodium-dependent reabsorption in renal tubules.

Storage. Store at room temperature (20-25C) in a cool, dry place. Capsules shelf-stable for 24+ months.

Regulatory status

Classified as a dietary supplement in the US (no FDA pre-approval). Available widely over the counter at low doses. Pharmaceutical lithium (lithium carbonate, lithium citrate) requires prescription. Some countries have regulated lithium orotate due to safety concerns. Generally Recognized as Safe at supplement doses (<20mg elemental); pharmaceutical-range doses require monitoring.

Put it to work

Calculate, log & track

Open Lithium Orotate straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open Lithium Orotate in the app →

Go deeper

The guide & community

The complete Lithium Orotate walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗

Open in app Community